Sheaff Brock Investment Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$244K	Hold	4,000	–	–	0.02%	364
2024 Q4	$360K	Hold	4,000	–	–	0.03%	306
2024 Q3	$515K	Hold	4,000	–	–	0.05%	250
2024 Q2	$454K	Hold	4,000	–	–	0.04%	260
2024 Q1	$531K	Hold	4,000	–	–	0.03%	279
2023 Q4	$488K	Buy	+4,000	New	+$306K	0.04%	272
2023 Q2	–	Sell	-830	Closed	-$81.5K	–	514
2023 Q1	$81.5K	Buy	+830	New	+$113K	0.01%	491

Other funds holding LABU

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sheaff Brock Investment Advisors's LABU Position: Q1 2025 in Review

Sheaff Brock Investment Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q1 2025 at 4,000 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #364.

Sheaff Brock Investment Advisors first reported a position in LABU in Q1 2023 and has held it in 7 quarters since. The position peaked at $531K in Q1 2024. 34 funds tracked by Wall St. Rank hold LABU as of Q1 2025.

Sheaff Brock Investment Advisors held 4,000 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $244K as of Q1 2025.
Sheaff Brock Investment Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q1 2025.
Direxion Daily S&P Biotech Bull 3X ETF made up 0.02% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #364 holding.
Sheaff Brock Investment Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and has held it in 7 quarters since.
Sheaff Brock Investment Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $531K in Q1 2024.
34 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.